Medicine shortage can occur unexpectedly and for many reasons, such as: manufacturing problems, unmet quality standard, increased demand, discontinued medicine, delays in production and more. These shortages have direct impact on patient’s health as often, when in critical need, these medications are not available for patients. Therefore, SK-Pharma Group is determined to address the issue of medicine on short supply in order to minimize its effect on patients.

We formed an alliance with many local partners and health authorities in our targeted countries. This allows us to comply with local regulations and respond to shortages very quickly.  Over the years, SK-Pharma Group has developed a strong partnership with many manufacturers and suppliers of medicinal products. Therefore, when a shortage occurs, we can obtain and secure a stock directly from our partners in a short lead time, competitive rates and high inventory access. Through our significant list of partners, we can access a robust and divers product portfolio.

To make sure the information we obtain is accurate and relevant, we have also developed a technological platform in which an algorithm gathers information about global shortages and notifies us in real time. This model, along with the flatform’s machine learning capability, allows us to be prepared for shortages and supply many due to the powerful basis that we have built. Therefore, we can offer an end to end solution when it comes solving medicinal shortages.